<unk>  is an ileal bile acid transporter inhibitor that is FDA approved for the treatment of cholestatic pruritus associated with Alagille syndrome.   Common adverse reactions include liver test abnormalities, abdominal pain, fat-soluble vitamin deficiency, diarrhea, bone fractures, and gastrointestinal bleeding.
Maralixibat
Domiphen
Miglustat
Tasimelteon
Migalastat
Metizoline
Aglepristone
Clobenzorex